Should Modest Elevations in Prostate-Specific Antigen, International Prostate Symptom Score, or Their Rates of Increase Over Time be Used as Surrogate Measures of Incident Benign Prostatic Hyperplasia?

Although surrogate measures of benign prostatic hyperplasia (BPH) are often used in epidemiologic studies, their performance characteristics are unknown. Using data from the Prostate Cancer Prevention Trial (n = 5,986), we evaluated prostate-specific antigen (PSA), International Prostate Symptom Sco...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Schenk, Jeannette M., Hunter-Merrill, Rachel, Zheng, Yingye, Etzioni, Ruth, Gulati, Roman, Tangen, Catherine, Thompson, Ian M., Kristal, Alan R.
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2013
Matèries:
Original Contributions
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3755644/
https://ncbi.nlm.nih.gov/pubmed/23813705
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/aje/kwt044
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars